Search
Close this search box.
Search
Close this search box.

English

Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia

Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients around the world by leveraging Bristol Myers Squibb’s long-standing expertise in immune-mediated diseases Zenas will receive a $50 million up-front cash payment and an equity investment from Bristol Myers Squibb, along with additional potential milestone-based payments and royalties in

Sabin Vaccine Institute Leads Public and Private Sector Fight to Prevent HPV and End Cervical Cancer with Global HPV Consortium Launch in Kuala Lumpur

KUALA LUMPUR, Malaysia, Sept. 05, 2023 (GLOBE NEWSWIRE) — The Global HPV Consortium, a worldwide public and private collaboration focused on accelerating prevention of Human Papillomavirus (HPV) and eliminating cervical cancer, launched today in Kuala Lumpur, Malaysia. The Sabin Vaccine Institute will lead the Consortium as its Secretariat. “We are

AI-Media and Middleman Announce Ad Insertion Partnership

Middleman and AI-Media Enter New Ad Insertion Partnership BROOKLYN, N.Y., Aug. 31, 2023 (GLOBE NEWSWIRE) — AI-Media, and Middleman Software, Inc., a leading provider of SCTE 104 and 35 messaging solutions, have joined forces to offer broadcasters a powerful, unified SCTE 104/35 messaging solution for live production workflows. AdIT: Middleman